[1]LEE WM, LARSON AM, STRAVITZ RT.AASLD position paper:The management of acute liver failure:Update 2011[J].Hepatology, 2011, 55:1-22.
|
[2]European Association for the Study of the Liver.EASL clinical practical guidelines on the management of acute (fulminant) liver failure[J].J Hepatol, 2017, 66 (5) :1047-1081.
|
[3]HERRINE SK, MOAYYEDI P, BROWN RS Jr, et al.American Gastroenterological Association Institute technical review on initial testing and management of acute liver disease[J].Gastroenterology, 2017, 52 (3) :648-664.e5.
|
[4]WANG YM, YAN GH.A new understanding of the typing and diagnosis of liver failure[J].J Inter Intens Med, 2016, 22 (3) :161-166. (in Chinese) 王宇明, 闫国华.肝衰竭分型机制及诊断研究的新认识[J].内科急危重症杂志, 2016, 22 (3) :161-166.
|
[5]BERNAL W, HYYRYLAINEN A, GERA A, et al.Lessons from look-back in acute liver failure?A single centre experience of 3300 patients[J].J Hepatol, 2013, 59 (1) :74-80.
|
[6]FONTANA RJ, ELLERBE C, DURKALSKI VE, et al.2-year outcomes in initial survivors with acute liver failure:Results from a prospective, multicenter study[J].Liver Int, 2015, 35 (2) :370-380.
|
[7]ESCORSELL A, MAS A, de la MATA M, et al.Acute liver failure in Spain:Analysis of 267 cases[J].Liver Transpl, 2007, 13 (10) :1389-1395.
|
[8]TREY C, DAVIDSON CS.The management of fulminant hepatic failure[J].Prog Liver Dis, 1970, 3 (3) :282-298.
|
[9]BERNUAU J, RUEFF B, BENHAMOU JP.Fulminant and subfulminant liver failure:Definitions and causes[J].Semin Liver Dis, 1986, 6 (2) :97-106.
|
[10]O'GRADY JG, SCHALM SW, WILLIAMS R.Acute liver failure:Redefining the syndromes[J].Lancet, 1993, 342 (8866) :273-275.
|
[11]TANDON BN, BERNAUAU J, O'GRADY J, et al.Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure[J].JGastroenterol Hepatol, 1999, 14 (5) :403-404.
|
[12]MOCHIDA S, TAKIKAWA Y, NAKAYAMA N, et al.Diagnostic criteria of acute liver failure:A report by the intractable hepatobiliary diseases study group of Japan[J].Hepatol Res, 2011, 41 (9) :805-812.
|
[13] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association;Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.Guidelines for diagnosis and treatment liver failure[J].Chin J Clin Infect Dis, 2012, 5 (6) :321-327. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华临床感染病杂志, 2012, 5 (6) :321-327.
|
[14]MANKA P, VERHEYEN J, GERKEN G, et al.Liver failure due to acute viral hepatitis (A-E) [J].Visc Med, 2016, 32 (5) :80-85.
|
[15]ZHAO P, WANG CY, LIU WW, et al.Causes and outcomes of acute liver failure in China[J].PLo S One, 2013, 8 (11) :e80991.
|
[16]WANG CY, ZHAO P, LIU WW, et al.Acute liver failure caused by severe acute hepatitis B:A case series from a multi-center investigation[J].Ann Clin Microbiol Antimicrob, 2014, 13:23.
|
[17]FUJIWARA K, YOKOSUKA O, EHATA T, et al.Association between severity of type A hepatitis and nucleotide variations in the 50non-translated region of hepatitis A virus RNA:strains from fulminant hepatitis have fewer nucleotide substitutions[J].Gut, 2002, 51 (1) :82-88.
|
[18]LIU XY, CHEN J, WANG XX, et al.Etiological analysis of 3233 patients with acute liver failure, subacute liver failure and acute-onchronic liver failure[J].Clin Med Engineering, 2012, 19 (5) :823-825. (in Chinese) 刘晓燕, 陈婧, 王晓霞, 等.3233例急性、亚急性、慢加急性肝衰竭病因特点分析[J].临床医学工程, 2012, 19 (5) :823-825.
|
[19]NING GX, LI L, HOU JL, et al.Etiology and clinical features of acute-on-chronic liver failure and their association with prognosis[J].Hebei Med J, 2017, 39 (2) :214-216. (in Chinese) 宁更献, 李力, 侯军良, 等.慢加急性肝衰竭病因、临床特点与预后关系分析[J].河北医药, 2017, 39 (2) :214-216.
|
[20]SEBASTIANI M, ATZENI F, MILAZZO L, et al.Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis[J].Joint Bone Spine, 2017, 84 (5) :525-530.
|
[21]PATTULLO V.Prevention of hepatitis B reactivation in the setting of immunosuppression[J].Clin Mol Hepatol, 2016, 22 (2) :219-237.
|
[22]CALLE SERRANO B, GRO HENNIG A, HOMS M, et al.Development and evaluation of a baseline-event-anticipation score for hepatitis delta[J].J Viral Hepat, 2014, 21 (11) :e154-163.
|
[23]ARENDS J, GHISETTI V, IRVING W, et al.Hepatitis E:An emerging infection in high income countries[J].J Clin Virol, 2014, 59 (2) :81-88.
|
[24]SHARMA S, KUMAR A, KAR P, et al.Risk factors for vertical transmission of hepatitis E virus infection[J].J Viral Hepat, 2017, 24 (11) :1067-1075.
|
[25]REUBEN A, KOCH DG, LEE WM, et al.Drug induced acute liver failure:Results of a U.S.multicenter, prospective study[J].Hepatology, 2010, 52 (6) :2065-2076.
|
[26]FORREST JA, CLEMENTS JA, PRESCOTT LF.Clinical pharmacokinetics of paracetamol[J].Clin Pharmacokinet, 1982, 7 (2) :93-107.
|
[27]LARSON AM.Acetaminophen hepatotoxicity[J].Clin Liver Dis, 2007, 11 (3) :525-548.
|
[28]HODGMAN MJ, GARRARD AR.A review of acetaminophen poisoning[J].Crit Care Clin, 2012, 28 (4) :499-516.
|
[29]BUNCHORNTAVAKUL C, REDDY KR.Acetaminophen-related hepatotoxicity[J].Clin Liver Dis, 2013, 17 (4) :593.
|
[30]ROBERTS DW, LEE WM, HINSON JA, et al.An immunoassay to rapidly measure acetaminophen protein adducts accurately identifies patients with acute liver injury or failure[J].Clin Gastroenterol Hepatol, 2017, 15 (4) :555-562.e3.
|
[31]O'GRADY J.Timing and benefit of liver transplantation in acute liver failure[J].J Hepatol, 2013, 60 (3) :663-670.
|
[32]HUO T, WU JC, SHENG WY, et al.Prognostic factor analysis of fulminant and subfulminant hepatic failure in an area endemic for hepatitis B[J].J Gastroenterol Hepatol, 1996, 11 (6) :560-565.
|
[33]KAMATH PS, WIESNER RH, MALINCHOC M, et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology, 2001, 33 (2) :464-470.
|
[34]MALINCHOC M, KAMATH PS, GORDON FD, et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J].Hepatology, 2000, 31 (4) :864-871.
|
[35]MARTIN EF, O’BRIEN C.Update on MELD and organ allocation[J].Clin Liver Dis, 2015, 5 (4) :105-107.
|
[36]CHRISTENSEN E.Prognostic models including the Child Pugh, MELDand Mayo risk scores:Where are we and where should we go?[J].JHepatol, 2004, 41 (2) :344-350.
|
[37]KARKHANIS J, VERNA EC, CHANG MS, et al.Steroid use in acute liver failure[J].Hepatology, 2014, 59 (2) :612-621.
|
[38]ZHAO B, ZHANG HY, XIE GJ, et al.Evaluation of the efficacy of steroid therapy on acute liver failure[J].Exp Ther Med, 2016, 12 (5) :3121-3129.
|
[39]ZHANG HY, ZHANG XQ.Predictive model for the efficacy of glucocorticoids in treating acute-on-chronic preliver failure and roadmap[J].Chin J Gastroenterol Hepatol, 2016, 25 (5) :495-498. (in Chinese) 张辉艳, 张绪清.糖皮质激素治疗慢加ALF前期的疗效预测模型与路线图[J].胃肠病学和肝病学杂志, 2016, 25 (5) :495-498.
|
[40]GAO L, SHI XF.Research advances in the antiviral therapy for hepatitis B-related acute-on-chronic liver failure[J].Chongqing Med, 2016, 45 (7) :980-982. (in Chinese) 高莉, 石小枫.乙型肝炎相关慢加ALF抗病毒治疗的研究进展[J].重庆医学, 2016, 45 (7) :980-982.
|
[41]SALIBA F, CAMUS C, DURAND F, et al.Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure:A randomized, controlled trial[J].Ann Intern Med, 2013, 159 (8) :522-531.
|
[42]BERNUAU J.High volume plasma exchange in patients with acute liver failure[J].J Hepatol, 2016, 65 (3) :646-647.
|
[43]LARSEN FS, SCHMIDT LE, BERNSMEIER C, et al.High-volume plasma exchange in patients with acute liver failure:An open randomised controlled trial[J].J Hepatol, 2016, 64 (1) :69-78.
|
[44]DHAWAN A, STROM SC, SOKAL E, et al.Human hepatocyte transplantation[J].Methods Mol Biol, 2010, 640:525-534.
|
[45]DHAWAN A, PUPPI J, HUGHES RD, et al.Human hepatocyte transplantation:Current experience and future challenges[J].Nat Rev Gastroenterol Hepatol, 2010, 7 (5) :288-298.
|
[46] BERNAL W, HYYRYLAINEN A, GERA A, et al.Lessons from look-back in acute liver failure?A single centre experience of 3300 patients[J].J Hepatol, 2013, 59 (1) :74-80.
|
[47]GERMANI G, THEOCHARIDOU E, ADAM R, et al.Liver transplantation for acute liver failure in Europe:Outcomes over 20 years from the ELTR database[J].J Hepatol, 2012, 57 (2) :288-296.
|